HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Julia Lichtnekert Selected Research

Skin Diseases (Skin Disease)

9/2011Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Julia Lichtnekert Research Topics

Disease

7Inflammation (Inflammations)
01/2016 - 09/2009
6Glomerulonephritis
11/2014 - 08/2007
5Lupus Nephritis
01/2022 - 05/2010
4Nephritis
11/2014 - 04/2009
3Renal Insufficiency (Renal Failure)
01/2022 - 03/2010
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
02/2015 - 09/2011
3Immune Complex Diseases (Immune Complex Disease)
11/2011 - 08/2007
3Type 2 Diabetes Mellitus (MODY)
07/2011 - 03/2010
2Necrosis
08/2012 - 11/2009
2Lung Diseases (Lung Disease)
11/2011 - 09/2011
2Virus Diseases (Viral Diseases)
11/2009 - 09/2009
1Acute Kidney Injury (Acute Renal Failure)
01/2024
1Drug-Related Side Effects and Adverse Reactions
01/2022
1Chronic Renal Insufficiency
01/2022
1Ischemia
01/2020
1Wilms Tumor (Wilm's Tumor)
12/2016
1Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
06/2015
1Hypergammaglobulinemia (Hyperimmunoglobulinemia)
02/2015
1Autoimmune Diseases (Autoimmune Disease)
02/2015
1Sepsis (Septicemia)
09/2011
1Skin Diseases (Skin Disease)
09/2011
1Atrophy
01/2011
1Diabetic Nephropathies (Diabetic Nephropathy)
06/2010
1Kidney Diseases (Kidney Disease)
05/2010
1Infections
05/2010
1Cardiomyopathies (Cardiomyopathy)
03/2010
1Hypertrophy
03/2010
1Albuminuria
03/2010
1Melanoma (Melanoma, Malignant)
11/2009

Drug/Important Bio-Agent (IBA)

5Antigen-Antibody Complex (Immune Complex)IBA
02/2015 - 08/2007
4CytokinesIBA
01/2016 - 11/2009
3RNA (Ribonucleic Acid)IBA
01/2020 - 08/2007
3AutoantibodiesIBA
02/2015 - 08/2007
3Immunoglobulin G (IgG)IBA
02/2015 - 09/2011
3Histones (Histone)IBA
08/2012 - 03/2010
2Proteins (Proteins, Gene)FDA Link
12/2016 - 11/2014
2InflammasomesIBA
11/2014 - 01/2011
2DNA (Deoxyribonucleic Acid)IBA
11/2011 - 09/2009
2Antiviral Agents (Antivirals)IBA
05/2010 - 09/2009
2Interferon Type IIBA
05/2010 - 11/2009
2Messenger RNA (mRNA)IBA
03/2010 - 11/2009
2Viral RNAIBA
11/2009 - 08/2007
2Toll-Like Receptors (Toll-Like Receptor)IBA
11/2009 - 08/2007
1Interleukin-22 (IL-22)IBA
01/2024
1Immunomodulating AgentsIBA
01/2022
1Cisplatin (Platino)FDA LinkGeneric
01/2020
1IntegrinsIBA
12/2016
1ChemokinesIBA
01/2016
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
06/2015
1Immunoglobulin M (IgM)IBA
02/2015
1RO5461111IBA
02/2015
1ElementsIBA
02/2015
1cathepsin SIBA
02/2015
1InterleukinsIBA
11/2014
1nutlin 3IBA
11/2011
1AutoantigensIBA
11/2011
1Protein CIBA
09/2011
1Complement C3 (C3 Complement)IBA
09/2011
1Interleukin-12 (IL 12)IBA
09/2011
1Chemokine ReceptorsIBA
07/2011
1Interleukin-18 (Interleukin 18)IBA
01/2011
1Interleukin-1 (Interleukin 1)IBA
01/2011
1antiglomerular basement membrane antibodyIBA
01/2011
1ChromatinIBA
06/2010
1Serine (L-Serine)FDA Link
06/2010
1Interferon-alpha (Interferon Alfa)IBA
05/2010
1Interferon-betaIBA
05/2010
1InterferonsIBA
11/2009
1LipidsIBA
11/2009
1Fc Receptors (Fc Receptor)IBA
09/2009
1Nucleic AcidsIBA
09/2009
1Toll-Like Receptor AgonistsIBA
04/2009
1Imiquimod (Aldara)FDA LinkGeneric
08/2007
1Interleukin-6 (Interleukin 6)IBA
08/2007

Therapy/Procedure

1Therapeutics
01/2022
1Ligation
08/2007